Microvast Holdings, Inc.
Microvast Holdings, Inc. (MVST) Financial Performance & Income Statement Overview
Explore the financials of Microvast Holdings, Inc. (MVST), including yearly and quarterly data on income, cash flow, and balance sheets.
Microvast Holdings, Inc. (MVST) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Microvast Holdings, Inc. MVST financial performance.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $116.49M | $113.39M | $101.39M | $83.67M |
Cost of Revenue | $73.47M | $71.87M | $67.78M | $56.48M |
Gross Profit | $43.02M | $41.52M | $33.61M | $27.20M |
Gross Profit Ratio | $0.37 | $0.37 | $0.33 | $0.33 |
R&D Expenses | $8.25M | $8.77M | $10.69M | $10.11M |
SG&A Expenses | $17.25M | $29.34M | $16.80M | $28.54M |
Operating Expenses | $25.50M | $24.59M | $26.43M | $38.64M |
Total Costs & Expenses | $98.97M | $96.46M | $95.27M | $85.07M |
Interest Income | $177000.00 | $191000.00 | $186000.00 | $246000.00 |
Interest Expense | $1.19M | $1.59M | $4.29M | $2.09M |
Depreciation & Amortization | $8.18M | $7.81M | $7.72M | $7.63M |
EBITDA | $71.16M | -$96.03M | $25.26M | -$91.83M |
EBITDA Ratio | $0.61 | -$0.85 | $0.25 | -$1.10 |
Operating Income | $18.93M | -$24.53M | $7.19M | -$75.63M |
Operating Income Ratio | $0.16 | -$0.22 | $0.07 | -$0.90 |
Other Income/Expenses (Net) | $42.86M | -$81.44M | $6.06M | -$2.81M |
Income Before Tax | $61.79M | -$105.44M | $13.25M | -$78.44M |
Income Before Tax Ratio | $0.53 | -$0.93 | $0.13 | -$0.94 |
Income Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 |
Net Income | $61.79M | -$105.44M | $13.25M | -$101.56M |
Net Income Ratio | $0.53 | -$0.93 | $0.13 | -$1.21 |
EPS | $0.19 | -$0.26 | $0.04 | -$0.25 |
Diluted EPS | $0.05 | -$0.26 | $0.04 | -$0.25 |
Weighted Avg Shares Outstanding | $323.43M | $322.33M | $320.55M | $315.51M |
Weighted Avg Shares Outstanding (Diluted) | $374.43M | $322.33M | $367.03M | $315.51M |
Financial performance has remained strong, with revenue growing from $83.67M in Q2 2024 to $116.49M in Q1 2025. Gross profit continued to perform well, with margins at 37% in the latest quarter. Operating income reached $18.93M in Q1 2025, holding a steady 16% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $71.16M. Net income rose to $61.79M, keeping EPS at $0.19. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan